Hashimoto’s Encephalopathy with Use of Intravenous Immunoglobulin as First-Line Therapy

0Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Hashimoto’s encephalopathy is an uncommon cause of altered mental status in hospitalized patients and is challenging to diagnose, particularly in the presence of other psychiatric comorbidities. Corticosteroids are the primary treatment. Here, we present a patient with history of post-traumatic stress disorder and prior substance abuse admitted with profound altered mental status and agitation requiring admission to the intensive care unit and mechanical ventilation. He was treated with intravenous immunoglobulin (IVIG) instead of the standard steroid course because of concerns for worsening agitation. The patient had improvement with IVIG infusions, returned to a functional state, and has remained on IVIG therapy monthly since the initial episode without any disease recurrence.

Cite

CITATION STYLE

APA

Barrett, L. D., Ballew, M., & Ewers, E. (2023). Hashimoto’s Encephalopathy with Use of Intravenous Immunoglobulin as First-Line Therapy. Military Medicine, 188(9–10), e3276–e3279. https://doi.org/10.1093/milmed/usad264

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free